logo

For the Inventor, By the Inventor

Miramar, FL, United States of America

Altor Bioscience Corporation


USPTO Granted Patents = 61



Trademarks = 2

Forward Citations = 861

Loading Chart...
Loading Chart...

38 inventors (with patents filed for the assignee):

goldMedal Hing C Wong (59 out of 104 patents)

silverMedal Peter Rhode (46 out of 48 patents)

bronzeMedal Bai Liu (35 out of 37 patents)

4.  Xiaoyun Zhu (23 out of 25 patents)

5.  Wenxin Xu (15 out of 17 patents)

6.  Warren Marcus (11 out of 11 patents)

7.  Kai-ping Han (11 out of 12 patents)

8.  Kai-Ping Han (9 out of 10 patents)

9.  Robert Newman (8 out of 8 patents)

10.  Lijing You (8 out of 8 patents)

11.  Lin Kong (6 out of 6 patents)

12.  Kimberlyn F Card (5 out of 5 patents)

13.  Jon A Weidanz (4 out of 4 patents)

14.  Marilyn Fernandez (3 out of 3 patents)

15.  Linda A Sherman (3 out of 4 patents)


Core Competencies:
IL-15 Variants
Multimeric IL-15 Molecules
Fusion Molecules
T Cell Receptors
Neoplasia Treatment
Immune Checkpoint Inhibitors
BCG Compositions
HIV Inhibition
Anti-CD20 Antibody
Anti-PDL1 Molecules
CTLA-4 Antibody
TGF-Beta Receptor

61 patents:

1. 12410224 - IL-15-based fusions to IL-7 and IL-21 (2025-09-09),
2. 12371472 - Multimeric IL-15 soluble fusion molecules and methods of making and using same (2025-07-29),
3. 12325734 - Human immunodeficiency virus-specific T cell receptors (2025-06-10),
4. 12318432 - BCG and IL-15 based molecules (2025-06-03),
5. 12268732 - IL-15-based molecules with anti-CD20 antibody and methods of use (2025-04-08),
6. 12268731 - Compositions comprising IL-15N72D-based molecules and bacillus calmette-guerin (BCG) (2025-04-08),
7. 12233116 - IL-15-based fusions to IL-12 and IL-18 (2025-02-25),
8. 12186372 - IL-15-based molecules and methods of treating a neoplasia (2025-01-07),
9. 12168680 - Fusion molecules and IL-15 variants (2024-12-17),
10. 12097244 - Methods of treating a neoplasia with IL-15-based molecules and CTLA-4 antibody (2024-09-24),
11. 11992516 - Compositions comprising IL-15-based molecules and immune checkpoint inhibitor antibodies (2024-05-28),
12. 11975059 - IL-15-based fusions to IL-12 and IL-18 (2024-05-07),
13. 11965007 - IL-15-based fusions to IL-7 and IL-21 (2024-04-23),
14. 11925676 - Method for treating neoplasia with an anti-CD38 antibody and an IL-15:IL-15R complex (2024-03-12),
15. 11890323 - Method of treating cancer with composition comprising IL-15-based molecules and BCG (2024-02-06),
Altor Bioscience Corporation is a leading biotechnology company specializing in the development of innovative immunotherapies. With a focus on oncology and infectious diseases, Altor Bioscience aims to improve patient outcomes by advancing the field of immune-based therapies. Through groundbreaking research and clinical trials, the company strives to bring safe and effective treatments to market. Together with a team of dedicated scientists and collaborators, Altor Bioscience is committed to making a lasting impact on global healthcare.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Dec 16 2025

...
61 Patents

#1 in Miramar, FL

#127 in Florida

#5,704 in US

#11,489 in the World

...
Miramar, FL, United States of America

Altor Bioscience Corporation

Forward Citations = 861

38 inventors:

goldMedal Hing C Wong (59 out of 104 patents)

silverMedal Peter Rhode (46 out of 48 patents)

bronzeMedal Bai Liu (35 out of 37 patents)

4.  Xiaoyun Zhu (23 out of 25 patents)

5.  Wenxin Xu (15 out of 17 patents)

Please report any incorrect information to support@idiyas.com
Loading…